Fatty acids & cardiovascular function
This article was originally published in The Tan Sheet
Executive Summary
Consumption of EPA or DHA may reduce risk of adverse cardiovascular events by increasing systemic arterial compliance (SAC) and lowering total vascular resistance, according to study by Paul Nestel, Baker Medical Research Institute, Melbourne, Australia, et al., in August's American Journal of Clinical Nutrition. Researchers randomized 38 dyslipidemic subjects to receive either 3 g EPA/day, 3 g DHA/day or placebo for seven weeks. Primary endpoints measured were arterial functions, while secondary endpoints consisted of plasma lipid and plasma fatty acid levels. EPA group experienced 36% increase in SAC, which reflects arterial elasticity, while the DHA group saw a 27% increase. Test material was supplied by Hoffmann-La Roche and encapsulated by RP Scherer...